Clinical Trial Update: Hemodynamic Effects of Modulating Circulating Ketone Bodies With 1,3-butanediol [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating how modulating circulating ketone bodies with 1,3-butanediol affects hemodynamics in heart failure; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• 1,3-butanediol

Snippet

Sponsor: Aarhus University Hospital | Conditions: Heart Failure | Phase 2 | Status: COMPLETED